Directorate change
April 28, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces
that Olivier Bohuon, Non-Executive Director of the Company, has been appointed
as a member of the Remuneration Committee with immediate effect.
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience,
Gastrointestinal and Internal Medicine and we are developing treatments for
symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas, such as Ophthalmics.
www.shire.com